TIVC_OUT_1 [2025-04-03 04:15:38 -0400] 2580 Bytes | 727 tokens | Cum: 727 tkns (9.09% of 8k)
==========================================================================

You're the expert here today. So, I pulled together a bunch of data for you to look over real fast. I'm looking at high-performance stocks today and Tivic Health Systems (TIVC) hit my radar screen, up to 4.85 from a prev close of 3.25 Do you think its got more juice or is it lacking potential? It's 4:15:38 AM on Thu Apr 03, 2025 -0400 and I have to decide: buy or sell!

--- COMPANY PROFILE ---
Company: Tivic Health Systems (TIVC)
IPO: IPO date unknown
Shares Outstanding: 620,000
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange: XNAS

Here's the first list of news for Tivic Health Systems:

C1 - Mar-21-25 06:32PM - Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript
C2 - Mar-21-25 06:32PM 04:00PM - Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth
C3 - Mar-13-25 04:59PM - Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast
C4 - Mar-06-25 08:15AM - Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System
C5 - Mar-05-25 08:15AM - Tivic Health Systems, Inc. Announces Reverse Stock Split
C6 - Mar-03-25 08:15AM - Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve
C7 - Feb-24-25 08:15AM - Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team
C8 - Feb-12-25 08:30AM - Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma

Prior AI Reports for TIVC:
1. 2025-04-02 – Score: 15 – Target: 3.3000 – Highs: 3.9799 / – / –
company-struggles-amidst-sharp-performance-decline-outlook-gloomy

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Tivic Health Systems (TIVC)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

TIVC_OUT_3 [2025-04-03 04:15:41 -0400] 732 Bytes | 233 tokens | Cum: 962 tkns (12.03% of 8k)
==========================================================================

Showing C1 (chunk 1 of 1): C1:
**Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript**
Date: Mar-21-25 06:32PM
Source: (SeekingAlpha)
URL: https://seekingalpha.com/article/4769610-tivic-health-systems-inc-tivc-q4-2024-earnings-call-transcript?utm_source=finviz.com&utm_medium=referral&feed_item_type=transcript

Error fetching article: 403 Client Error: Forbidden for url: https://seekingalpha.com/article/4769610-tivic-health-systems-inc-tivc-q4-2024-earnings-call-transcript?utm_source=finviz.com&utm_medium=referral&feed_item_type=transcript

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TIVC_OUT_5 [2025-04-03 04:15:42 -0400] 978 Bytes | 302 tokens | Cum: 1324 tkns (16.55% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-24T07:30:19Z - KB Home, Intuitive Machines And 3 Stocks To Watch Heading Into Monday - Castor Maritime (NASDAQ:CTRM...
A2 - 2025-03-21T22:32:02Z - Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript...
A3 - 2025-03-21T20:01:48Z - Tivic Health Systems GAAP EPS of -$19.68, revenue of $0.78M (NASDAQ:TIVC)...
A4 - 2025-03-21T20:00:23Z - Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation a...
A5 - 2025-03-21T08:32:07Z - Earnings Scheduled For March 21, 2025 - Biofrontera (NASDAQ:BFRI), 51 Talk Online Education (AMEX:CO...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

TIVC_OUT_7 [2025-04-03 04:15:49 -0400] 1098 Bytes | 332 tokens | Cum: 1658 tkns (20.72% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**KB Home, Intuitive Machines And 3 Stocks To Watch Heading Into Monday - Castor Maritime (NASDAQ:CTRM), Enerpac Tool Group (NYSE:EPAC)**Date: 2025-03-24Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/25/03/44452475/kb-home-intuitive-machines-and-3-stocks-to-watch-heading-into-mondayWith U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Wall Street expects KB Home KBH to report quarterly earnings at $1.58 per share on revenue of $1.50 billion after the closing bell, according to data from Benzinga Pro. KB Home shares gained 0.4% to $60.00 in after-hours trading. Tivic Health Systems Inc. TIVC posted a net loss of $5.7 million for the year ended Dec. 31, 2024, versus a year-ago loss of $8.2 million. Revenue (net of returns) fell to $0.8 million from $1.2

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TIVC_OUT_9 [2025-04-03 04:15:50 -0400] 1075 Bytes | 317 tokens | Cum: 2124 tkns (26.55% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-12-24T11:26:09Z - US Stocks To Open Higher On Shortened Trading Day: Santa Claus Rally Period Officially Begins, Says Analyst
B2 - 2024-03-26T17:45:27Z - Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B3 - 2024-03-26T12:00:29Z - Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
B4 - 2024-01-30T18:18:27Z - Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B5 - 2023-11-15T19:04:31Z - Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B6 - 2023-11-15T13:07:57Z - Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TIVC_OUT_11 [2025-04-03 04:15:53 -0400] 785 Bytes | 205 tokens | Cum: 2331 tkns (29.14% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**US Stocks To Open Higher On Shortened Trading Day: Santa Claus Rally Period Officially Begins, Says Analyst**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/24/12/42667439/us-stocks-to-open-higher-on-shortened-trading-day-as-santa-clause-rally-period-begins-says-analystUS stock futures are trading higher ahead of a shortened trading session on Christmas Eve. Analysts expect a 'Santa Rally' during this period, which has historically seen positive returns. However, they also caution about potential market corrections in 2025 due to stretched valuations.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TIVC_OUT_13 [2025-04-03 04:15:54 -0400] 1091 Bytes | 259 tokens | Cum: 2644 tkns (33.05% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-21 10-K Item 7 Mgts Discussion and Analysis of Fin Cond and Results of Oper

You should read the following discussion and analysis of our financial condition and operating results together with our financial statements and related notes included elsewhere in thi...

S2 - 2025-03-21 8-K Item 1.01 Entry into a Material Definitive Agrmt.

On March 18, 2025, Tivic Health Systems, Inc. (the Company) entered into an Equity Purchase Agrmt (the Purchase Agrmt) with Mast Hill Fund, L.P. (the Investor), pursuant to which the Company will have the right, but ...

S3 - 2025-03-21 10-K Item 7 Mgts Discussion and Analysis of Fin Cond and Results of Oper

You should read the following discussion and analysis of our financial condition and operating results together with our financial statements and related notes included elsewhere in thi...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TIVC_OUT_15 [2025-04-03 04:15:54 -0400] 1098 Bytes | 223 tokens | Cum: 2869 tkns (35.86% of 8k)
==========================================================================

Showing S1 (chunk 1 of 6): S1:
Item 7 Managements Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial condition and operating results together with our financial statements and related notes included elsewhere in this Report. This discussion and analysis contains forward-looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under Risk Factors or in other parts of this Report.

Overview

Tivic Health is a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health. Tivic Healths bioelectronic program is developing non-invasive

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TIVC_OUT_17 [2025-04-03 04:16:02 -0400] 1098 Bytes | 252 tokens | Cum: 3123 tkns (39.04% of 8k)
==========================================================================

Showing S1 (chunk 2 of 6): medical devices to meaningfully improve treatment options in neurologic, cardiac and autonomic-related diseases. Tivic Health currently offers a bioelectronic, FDA-approved over-the-counter device (ClearUP) that treats sinus pain, pressure and congestion. ClearUP is available through online retailers and commercial distributors and at tivichealth.com. Tivic Health is further developing its bioelectronic portfolio with a focus on non-invasive vagus nerve stimulation.

Tivic Healths biopharma program focuses on immunotherapeutics and the lead product candidate is the late-stage TLR5 agonist, Entolimod, to treat acute radiation syndrome. The FDA has granted Fast Track and Orphan Drug designation to Entolimod.

Business Overview

Bioelectronic medicine is an emerging market. Since our formation in September 2016, we have devoted substantially all of our efforts to the development and mark

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TIVC_OUT_19 [2025-04-03 04:16:08 -0400] 1098 Bytes | 259 tokens | Cum: 3579 tkns (44.74% of 8k)
==========================================================================

Showing S1 (chunk 3 of 6): eting of our proprietary technology platform to provide noninvasive, drug-free treatments and treatment candidates for various diseases and conditions. In 2019, we launched ClearUP in the U.S. market. ClearUP is approved by the FDA for sale in the U.S. for the two FDA-approved indications noted above. We currently sell ClearUP directly to consumers online through our own website and to resellers such as McKesson-affiliate Simply Medical, Cardinal Health and AmerisourceBergen. Through our online retailers, ClearUP is available through Amazon, McKesson, Optum Store, Walmart, Target, Best Buy, Cardinal Health and FSA/HSA Store. We have also developed a proprietary approach to precision, non-invasive cervical vagus nerve stimulation based on our experience building evidence-based bioelectronic therapies.

In early 2025, through the license with Statera, Tivic added biologic immunotherapy to

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

TIVC_OUT_21 [2025-04-03 04:16:19 -0400] 4344 Bytes | 1229 tokens | Cum: 4972 tkns (62.15% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+-----------------------+------------------------+
| Volume: 974,018 | Perf Month: -43.76% | Option/Short: No / No | Sales Y/Y TTM: -33.67% |
+---------------------+-----------------------+-----------------------+------------------------+
| Avg Volume: 629.09K | Perf Quarter: -37.59% | Short Float: 3.49% | ROE: -184.96% |
+---------------------+-----------------------+-----------------------+------------------------+
| Rel Volume: 1.55 | Index: - | Short Ratio: 0.03 | ROI: -223.08% |
+---------------------+-----------------------+-----------------------+------------------------+
| RSI (14): 42.63 | Market Cap: 2.02M | Short Interest: 0.02M | Sales Surprise: - |
+---------------------+-----------------------+-----------------------+------------------------+
| ATR (14): 0.66 | Shs Outstand: 0.62M | Beta: 2.16 | EPS Surprise: - |
+---------------------+-----------------------+-----------------------+------------------------+
| SMA20: 0.03% | Shs Float: 0.62M | Sales Q/Q: -49.58% | P/E: - |
+---------------------+-----------------------+-----------------------+------------------------+
| SMA50: -34.39% | Inst Own: 2.54% | Sales past 5Y: 25.51% | Earnings: Mar 21 AMC |
+---------------------+-----------------------+-----------------------+------------------------+
| SMA200: -38.70% | Insider Own: 0.14% | Employees: 9 | |
+---------------------+-----------------------+-----------------------+------------------------+
| Perf Week: 8.33% | Insider Trans: 0.00% | Debt/Eq: 0.00 | |
+---------------------+-----------------------+-----------------------+------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

No transactions recorded.

Inside Trans: Tivic Health Systems, Inc. (TIVC) by Handley Michael K (Chief Operating Officer) on 2025-02-21
- Restricted Stock Units: 600000 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 780000, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -5655000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 3.25
Average Volume: 98137.99
30-Day High: 5.7783
30-Day Low: 2.52

[Detailed Financials: TTM 2024]
- Total Assets: $2,807,000.0
- Total Liabilities: $272,000
- Total Equity: $2,535,000.0
- Current Assets: $2,639,000.0
- Current Liabilities: $272,000

[Income Statement: TTM 2024]
- Revenue: $780,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -19.68

[Cash Flow Statement: TTM 2024]
- Net Cash Flow: $0

[Detailed Financials: FY 2024]
- Total Assets: $2,807,000.0
- Total Liabilities: $272,000
- Total Equity: $2,535,000.0
- Current Assets: $2,639,000.0
- Current Liabilities: $272,000

[Income Statement: FY 2024]
- Revenue: $780,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -19.68

[Cash Flow Statement: FY 2024]
- Net Cash Flow: $0
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

TIVC_OUT_23 [2025-04-03 04:16:23 -0400] 676 Bytes | 167 tokens | Cum: 5367 tkns (67.09% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

TIVC_IN_25 [2025-04-03 04:16:24 -0400] 126 Bytes | 29 tokens | Cum: 5486 tkns (68.58% of 8k)
==========================================================================

====================================
[2025-04-03 04:16:24] # Analysis Completed
Elapsed Time: 46.48 seconds